Kevin Trimm

Chief Product Officer

Kevin Trimm is Chief Product Officer at Cytel. Kevin is a versatile leader with 20 years of experience at the intersection of data science technology and drug development. As our Chief Product Officer, he is responsible for Cytel’s software product strategy, development, and commercialization. Under Kevin’s leadership, Cytel is delivering a comprehensive and transformative software-as-a-service (SaaS) clinical trial design platform. The platform includes over 30 years of proprietary innovation, coupled with open-source technology and artificial intelligence.

Before Cytel, Kevin was Vice President of Product Management at Certara, leading multiple transformational software implementation projects in top-tier pharmaceutical companies. He developed and launched Certara’s first cloud-native SaaS offering and was also responsible for developing the strategic rationale for key technology acquisitions contributing to the success of Certara’s initial public offering.

Kevin is a PhD candidate at McGill University in the Department of Experimental Medicine where he is performing pharmaco-epidemiological. He holds an undergraduate degree from the University of Waterloo.

Kevin Trimm

Related Articles

Finding the Optimal Biological Dose with New PKBOIN-12 Method
Blog
October 16, 2025
Finding the Optimal Biological Dose with New PKBOIN-12 Method
Read More
How the Right Clinical Trial Design Software Boosts Success Rates
Interviews
November 28, 2024
How the Right Clinical Trial Design Software Boosts Success Rates
Read More
Commercial and Open-Source Software Synergy for Clinical Trial Design
Blog
April 5, 2024
Commercial and Open-Source Software Synergy for Clinical Trial Design
Read More